In the first issue of 2022, we report, among other things, on decision-making processes in baboon groups, introduce four new research projects, and present our photo contest award winners.
Cell culture studies show SARS-CoV-2 variant Omicron evades antibodies generated after infection and vaccination and is resistant to several therapeutic antibodies
In the last issue of this year, we report on what makes emerging coronavirus variants so dangerous, launch a new series on alternative methods at DPZ, and look back at our first Climate Day.
